XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Net sales $ 525.4 $ 523.8 $ 1,010.2 $ 1,024.0
Cost of products sold 421.7 414.9 833.9 831.1
Gross profit 103.7 108.9 176.3 192.9
Selling and general expense 57.2 65.1 120.5 126.7
Research and development expense 6.7 5.8 13.0 11.8
Intangible asset amortization expense 15.9 15.7 31.3 31.5
Total nonmanufacturing expenses 79.8 86.6 164.8 170.0
Goodwill impairment expense 0.0 0.0 411.9 0.0
Restructuring and other impairment expense 3.8 11.8 10.1 26.2
Operating profit (loss) 20.1 10.5 (410.5) (3.3)
Interest expense 18.6 18.4 36.4 36.7
Other income (expense), net 1.5 (1.1) (0.3) 0.6
Income (loss) before income taxes 3.0 (9.0) (447.2) (39.4)
Income tax expense (benefit), net 12.5 (7.6) (12.2) (10.0)
Net loss $ (9.5) $ (1.4) $ (435.0) $ (29.4)
Net loss per share:        
Basic (in dollars per share) $ (0.18) $ (0.03) $ (7.98) $ (0.54)
Diluted (in dollars per share) $ (0.18) $ (0.03) $ (7.98) $ (0.54)
Weighted average shares outstanding:        
Basic (in shares) 54,624,900 54,321,800 54,536,500 54,294,800
Diluted (in shares) 54,624,900 54,321,800 54,536,500 54,294,800